MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits

Inclusion Criteria: * Male or female. * ≥18 years old or legal age as per country requirement * Diagnosed with acute ischemic stroke with compatible brain imaging findings between 2 days to 10 days (inclusive) prior to inclusion. * NIHSS total score of 8 to 18 (inclusive) at the time of inclusion with a combined score of at least 3 on the NIHSS motor items 5A or 5B and/or 6A or 6B. * A candidate for active rehabilitation in the opinion of the treating physician. * Able to comply with the requirements of the protocol and provide written informed consent by patient or legal representative before any study-specific procedure is performed. Exclusion Criteria: * Pre-stroke modified Rankin score of \>1. * Contraindication to any of the study procedures. * Patients who became medically unstable within 24 hours after intravenous or endovascular thrombolysis or thrombectomy. * Intake of any herbal or traditional medicine within the past 30 days. * Participation in another investigational drug or device trial within the past 30 days. * Intake of warfarin in the past one week or expected to be on warfarin while in the study. * Women who are pregnant or wish to continue breastfeeding while in the study. Women of child-bearing potential may be included if they agree to strict abstinence or use of effective contraception, except systemically acting hormonal contraceptives. Hormone replacement therapy in menopausal/post-menopausal or surgically sterilized women is also not allowed while …